ALEXUS STEPHENS: Open Payments
NPI 1861000564 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 8 payments from 7 companies in 2025. Trend: 2023 $717 · 2024 $460 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $157 |
| PFIZER INC. | 1 | $119 |
| Smith+Nephew, Inc. | 1 | $101 |
| Calyxo, Inc. | 1 | $44 |
| TerSera Therapeutics LLC | 1 | $36 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
Products named: RYBREVANT, XTANDI, GRAFIX, CVAC ASPIRATION SYSTEM, Zoladex, PYLARIFY, GEMTESA, ERLEADA.
Industry payments across AZ — which companies pay providers there.
